Vonlerolizumab (MOXR 0916) is a humanized cancer[1].
[1]. Marin-Acevedo JA, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥3,600.00 | 现货 | 1 | |
| 5mg | ¥8,133.00 | 现货 | 1 | |
| 10mg | ¥10,573.00 | 现货 | 1 | |
| 25mg | ¥15,660.00 | 现货 | 1 | |
| 50mg | ¥21,168.00 | 现货 | 1 |
















Vonlerolizumab (MOXR 0916) is a humanized cancer[1].
[1]. Marin-Acevedo JA, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39.